Title : Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study.

Pub. Date : 2018 Apr 1

PMID : 29374054






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Purpose: Adjuvant sunitinib therapy compared with placebo prolonged disease-free survival (DFS) in patients with locoregional high-risk renal cell carcinoma (RCC) in the S-TRAC trial (ClinicalTrials.gov number NCT00375674). Sunitinib T cell receptor alpha constant Homo sapiens